$ACST 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Acasti is a biopharmaceutical innovator that has historically focused on the research, development and commercialization of prescription drugs using OM3 fatty acids delivered both as free fatty acids and bound-to-phospholipid esters, derived from krill oil. OM3 fatty acids have extensive clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia, or HTG. CaPre, an OM3 phospholipid therapeutic, was being developed for patients with severe HTG.

CEO

Janelle D'Alvise

Exchange

NASDAQ

Website

www.acastipharma.com

$0M

Total Revenue

32

Employees

$33M

Market Capitalization

-1.66

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Conversion Labs Inc CVLB 108548 35213 3.74 42.66 7.33
Royalty Pharma plc RPRX 18925 2239 2.81 15.20 43.40
Organon & Co. OGN 8905 7891 -4.60 5.10 22.06
Arvinas Inc ARVN 3725 21 7.48 -22.56 -782.93
Tilray Inc TLRY 3241 564 1.08 -8.14 -66.49
ATAI Life Sciences N.V. ATAI 2272 20 4.78 -10.40 -932.88
Cronos Group Inc CRON 2097 57 1.32 -14.52 -258.59
Usana Health Sciences Inc USNA 2079 1254 4.73 14.98 11.09
NRX Pharmaceuticals Inc NRXP 1170 2321 0.45 5.05 9.91
Phathom Pharmaceuticals Inc PHAT 1033 7.01 -6.45 None
Phibro Animal Health Corp. PAHC 893 833 3.70 16.25 6.53
Intersect ENT Inc XENT 893 103 21.65 -13.01 -66.55
Edgewise Therapeutics Inc EWTX 796 2.70 -29.55 None
Fulcrum Therapeutics Inc FULC 711 15 8.62 -9.63 -481.07
Pliant Therapeutics Inc PLRX 614 13 2.51 -7.16 -613.56
Cyteir Therapeutics Inc CYT 596 3.20 -20.62 None
Urovant Sciences Ltd UROV 503 -3.65 -3.08 None
Ikena Oncology Inc IKNA 404 10 2.18 -7.38 -551.28
Chromadex Corp CDXC 394 62 9.92 -16.62 -37.51
Provention Bio Inc PRVB 377 2.53 -2.94 None
Rain Therapeutics Inc RAIN 355 413 2.19 -11.66 123.20
Verrica Pharmaceuticals Inc VRCA 325 12 6.57 -8.92 -301.45
Evolus Inc EOLS 310 77 4.10 -2.08 -171.53
Adicet Bio Inc ACET 280 9 1.22 -4.97 -603.06
Terns Pharmaceuticals Inc TERN 252 1.40 -7.30 None
Milestone Pharmaceuticals Inc MIST 219 15 1.23 -7.37 -215.93
Kaleido Biosciences Inc KLDO 184 1 4.11 -2.07 None
Citius Pharmaceuticals Inc CTXR 179 2.24 -7.81 None
scPharmaceuticals Inc SCPH 167 119 2.45 -5.52 -27.05
Eyenovia Inc EYEN 143 6 16.29 -7.31 -324.94
Aquestive Therapeutics Inc AQST 142 42 -2.95 -2.21 -152.73
LifeMD Inc LFMD 139 64 -22.39 -1.00 -133.55
Eton Pharmaceuticals Inc ETON 124 15 6.13 -10.10 -74.52
Osmotica Pharmaceuticals Plc OSMT 122 190 2.37 -1.31 -47.85
Kala Pharmaceuticals Inc KALA 119 11 1.53 -0.94 None
Xeris Biopharma Holdings Inc XERS 111 34 12.19 -1.44 -248.46
Odonate Therapeutics Inc ODT 110 1.39 -0.94 None
Anebulo Pharmaceuticals Inc ANEB 102 7.93 -2.58 None
Opiant Pharmaceuticals Inc OPNT 100 37 3.03 -96.15 -3.06
Aerpio Pharmaceuticals Inc ARPO 99 15 2.98 -5.24 -28.77
Mannatech Inc MTEX 82 158 3.27 12.89 4.22
Natural Alternatives Internati NAII 80 179 1.07 7.90 6.03
India Globalization Capital In IGC 67 0 2.45 -7.60 -981.18
VYNE Therapeutics Inc VYNE 51 16 0.77 2.31 -554.66
Shineco Inc TYHT 44 3 2.17 -1.55 -159.60
Assertio Holdings Inc ASRT 36 117 0.49 -0.63 -38.05
Dermata Therapeutics Inc DRMA 36 -75.67 -7.32 None
Acasti Pharma Inc ACST 33 0 1.43 -1.66 -611.47
Nabriva Therapeutics Plc NBRV 29 12 0.88 -0.49 -452.55
Lexaria Bioscience Corp LEXX 27 1 3.76 -6.95 -445.15
Bio-Path Holdings Inc BPTH 26 0 1.19 -2.49 18.96
Reviva Pharmaceuticals Holding RVPH 25 1.41 -4.08 None
Baudax Bio Inc BXRX 25 1 -10.80 0.76 9.10
Trevi Therapeutics Inc TRVI 23 1.64 -0.66 None
Timber Pharmaceuticals Inc TMBR 20 0 8.79 0.68 -527.55
Hoth Therapeutics Inc HOTH 19 1.64 -2.02 None
Cyanotech Corp. CYAN 17 34 0.98 13.38 3.83
Sonoma Pharmaceuticals Inc. SNOA 11 17 3.32 -2.16 -31.96

Acasti Pharma Inc.’s (ACST) Outlook: Recollecting The Past For Future Insights

10d ago, source: stocksregister

Acasti Pharma Inc. (NASDAQ:ACST) price on Friday, October 08, fall -4.44% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.72. A look at the stock’s ...

Acasti Pharma outlines key benefits of recent Grace Therapeutics acquisition

11d ago, source: Proactiveinvestors

CEO Jan D’Alvise joined Proactive New York to discuss the Laval, Québec-based group's recent acquisition of Grace ...

Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan

13d ago, source: Le Lézard

Acasti Pharma Inc. ("Acasti" or the "Company") , today announces that the European Patent Office, Chinese Patent Office and the Mexican Patent Office have issued composition of matter patents for ...

Monteverde & Associates PC Filed A Class Action Lawsuit On Behalf Of Shareholders Of Acasti Pharma, Inc. In The Southern District Of New York

12d ago, source: Yahoo Finance

NEW YORK, NY / ACCESSWIRE / October 7, 2021 / Notice is hereby given that Monteverde & Associates PC has filed a class action lawsuit in the United States District Court the Southern District of ...

Acasti Pharma Inc. ACST

11d ago, source: Stockhouse

LAVAL, Qubec, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), today announces that the European Patent Office, Chinese Patent Office ...

Acasti Pharma Inc. Class A

5d ago, source: TheStreet.com

ACASTI PHARMA INC's gross profit margin for the first quarter of its fiscal year 2021 has significantly increased when compared to the same period a year ago. Sales have remained unchanged ...

Theratechnologies to Present at the H.C. Wainwright 5th Annual Nash Investor Conference

13d ago, source: Le Lézard

Theratechnologies Inc. (Theratechnologies) , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that Christian Marsolais, Ph.D., ...

Acasti Pharma Awarded Composition-of-Matter Patents for GTX-101 in Europe, China and Mexico and for GTX-102 in Japan

13d ago, source: Benzinga.com

LAVAL, Québec, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. ("Acasti" or the "Company") (NASDAQ:ACST, TSXV:ACST), today announces that the European Patent Office, Chinese Patent Office ...

Your Portfolio